Analysis of germline GLI1 variation implicates hedgehog signalling in the regulation of intestinal inflammatory pathways

Charlie W. Lees, William J. Zacharias, Mark Tremelling, Colin L. Noble, Elaine R. Nimmo, Albert Tenesa, Jennine Ochoa, Leif Torkvist, John Kao, Susan Farrington, Hazel E. Drummond, Gwo Tzer Ho, D. R. Ian Arnott, Henry D. Appelman, Lauri Diehl, Harry Campbell, Malcolm G. Dunlop, Miles Parkes, E. M. Sarah Howie, Deborah L. GumucioJack Satsangi

Research output: Contribution to journalArticle

45 Scopus citations

Abstract

Background: Ulcerative colitis (UC) and Crohn's disease (CD) are polygenic chronic inflammatory bowel diseases (IBD) of high prevalence that are associated with considerable morbidity. The hedgehog (HH) signalling pathway, which includes the transcription factor glioma-associated oncogene homolog 1 (GLI1), plays vital roles in gastrointestinal tract development, homeo-stasis, and malignancy. We identified a germline variation in GLI1 (within the IBD2 linkage region, 12q13) in patients with IBD. Since this IBD-associated variant encodes a GLI1 protein with reduced function and our expression studies demonstrated down-regulation of the HH response in IBD, we tested whether mice with reduced Gli1 activity demonstrate increased susceptibility to chemically induced colitis. Methods and Findings: Using a gene-wide haplotype-tagging approach, germline GLI1 variation was examined in three independent populations of IBD patients and healthy controls from Northern Europe (Scotland, England, and Sweden) totalling over 5,000 individuals. On log-likelihood analysis, GLI1 was associated with IBD, predominantly UC, in Scotland and England (p < 0.0001). A nonsynonymous SNP (rs2228226C→G), in exon 12 of GLI1 (Q1100E) was strongly implicated, with pooled odds ratio of 1.194 (confidence interval = 1.09-1.31, p = 0.0002). GLI1 variants were tested in vitro for transcriptional activity in luciferase assays. Q1100E falls within a conserved motif near the C terminus of GLI1; the variant GLI protein exhibited reduced transactivation function in vitro. In complementary expression studies, we noted the colonic HH response, including GLI1, patched (PTCH), and hedgehog-interacting protein (HHIP), to be down-regulated in patients with UC. Finally, GLI1+/lacz mice were tested for susceptibility to dextran sodium sulphate (DSS)-induced colitis. Clinical response, histology, and expression of inflammatory cytokines and chemokines were recorded. GLI1+/lacz mice rapidly developed severe intestinal inflammation, with considerable morbidity and mortality compared with wild type. Local myeloid cells were shown to be direct targets of HH signals and cytokine expression studies revealed robust up-regulation of IL-12, IL-17, and IL-23 in this model. Conclusions: HH signalling through GLI1 is required for appropriate modulation of the intestinal response to acute inflammatory challenge. Reduced GLI1 function predisposes to a heightened myeloid response to inflammatory stimuli, potentially leading to IBD.

Original languageEnglish (US)
Pages (from-to)1761-1775
Number of pages15
JournalPLoS Medicine
Volume5
Issue number12
DOIs
StatePublished - Dec 1 2008
Externally publishedYes

    Fingerprint

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Lees, C. W., Zacharias, W. J., Tremelling, M., Noble, C. L., Nimmo, E. R., Tenesa, A., Ochoa, J., Torkvist, L., Kao, J., Farrington, S., Drummond, H. E., Ho, G. T., Ian Arnott, D. R., Appelman, H. D., Diehl, L., Campbell, H., Dunlop, M. G., Parkes, M., Sarah Howie, E. M., ... Satsangi, J. (2008). Analysis of germline GLI1 variation implicates hedgehog signalling in the regulation of intestinal inflammatory pathways. PLoS Medicine, 5(12), 1761-1775. https://doi.org/10.1371/journal.pmed.0050239